B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

RSK activation

REACTOME PATHWAY
Reactome: R-HSA-4442577 genes27 compounds

The RSK activation pathway (Reactome ID: R-HSA-444257) involves 7 genes and is affected by 27 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

MAPK1MAPK3PDPK1RPS6KA1RPS6KA2RPS6KA3RPS6KA6

Compounds Affecting RSK activation

#CompoundTargets HitStudies
1sp600125117
2fisetin78
3Sorafenib300
4alsterpaullone12
5kenpaullone8
6plumbagin [Supplementary Concept]300
7pd980597
8isorhamnetin-3-O-beta-D-glucopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-6)-beta-D-galactopyranoside [Supplementary Concept] from300
9trametinib296
10withaferin300
11hydroxyfasudil [Supplementary Concept]11
12pictilisib25
13tyrphostin ag 14784
14Clotrimazole296
15Progesterone299
162-Chloroadenosine 2-Chloroadenosine.300
17Benzalkonium Compounds299
18Calcimycin216
19daph2
20Diphenhydramine14
21ha10044
22Lithocholic Acid300
23Loratadine296
24trequinsin hydrochloride1
25Kaempferols300
26Luteolin 5,7,3',4'-tetrahydroxy-flavone,150
27Afatinib297

About the RSK activation Pathway

The RSK activation pathway is catalogued in Reactome (ID: R-HSA-444257) and involves 7 genes. In the BiohacksAI corpus, 27 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include MAPK1, MAPK3, PDPK1, RPS6KA1, RPS6KA2.